Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 5969

BillFederalHouseIn Committee
LABEL Act
About This Bill
Committee
Latest Action · November 7, 2025
Referred to the House Committee on Energy and Commerce.
Congress
119th (2025–2027)
Introduced
November 7, 2025
Cosponsors (15)
0D 15R
View PDF ↗

Summary

Highlight any text to annotate
The LABEL Act would require abortion-inducing drugs to include labels identifying the name and address of the pharmacy or dispenser and the name of the prescribing doctor. The bill amends federal drug labeling requirements under the Food, Drug, and Cosmetic Act and prevents states from setting weaker labeling standards. The legislation defines "abortion-inducing drugs" as medications intended to terminate pregnancy or kill an unborn child, but explicitly excludes drugs used to treat ectopic pregnancies or remove deceased fetuses. The bill was referred to the House Committee on Energy and Commerce and includes a provision stating that if any part is found unconstitutional, the remainder would remain in effect.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.